Nutriband Inc. (NASDAQ:NTRBW – Get Free Report) shares were up 6.5% on Monday . The company traded as high as $1.65 and last traded at $1.32. Approximately 1,825 shares traded hands during mid-day trading, a decline of 77% from the average daily volume of 7,918 shares. The stock had previously closed at $1.24.
Nutriband Price Performance
The business’s fifty day simple moving average is $1.35 and its two-hundred day simple moving average is $1.02.
About Nutriband
Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.
See Also
- Five stocks we like better than Nutriband
- What is a Low P/E Ratio and What Does it Tell Investors?
- S&P 500 Hitting Resistance: These 3 Stocks Offer the Best Upside
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Nike’s Post-Earnings Drop Presents a Buying Opportunity
- 5 discounted opportunities for dividend growth investors
- Microsoft’s Targeted Upside Might Be Too Good to Ignore
Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.
